Statements (65)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:TS-19
|
| gptkbp:affects |
under investigation
|
| gptkbp:associated_with |
breakthrough infections
|
| gptkbp:clinical_trial |
ongoing for new vaccines
|
| gptkbp:community |
widespread in many regions
|
| gptkbp:community_impact |
notably less severe than in adults
|
| gptkbp:complications |
reported
|
| gptkbp:data_usage |
higher than previous variants
|
| gptkbp:descendant |
B.1.1.529
|
| gptkbp:discovered_by |
gptkb:2022
|
| gptkbp:distribution |
global
|
| gptkbp:genetic_diversity |
immune evasion
multiple spike protein mutations |
| gptkbp:healthcare |
increased testing and vaccination efforts
constantly updated important for community awareness affected by variant spread critical for managing outbreaks critical for managing outbreaks. monitor symptoms closely notable in pandemic progression significant on healthcare systems |
| https://www.w3.org/2000/01/rdf-schema#label |
Omicron BA.4
|
| gptkbp:impact |
on vaccination strategies
|
| gptkbp:is_monitored_by |
ongoing by health authorities
enhanced genomic surveillance required essential for public health safety |
| gptkbp:is_popular_in |
significant in late 2022
|
| gptkbp:is_recognized_by |
gptkb:South_Africa
|
| gptkbp:is_tested_for |
PCR and rapid tests effective
|
| gptkbp:is_vulnerable_to |
reduced compared to original strain
accelerated due to emergence |
| gptkbp:origin |
continuing to evolve
evolved from earlier Omicron strains |
| gptkbp:provides_information_on |
adapted to new variant information
masking and social distancing recommended |
| gptkbp:public_awareness |
increased due to media coverage
|
| gptkbp:related_model |
subject to change based on data
|
| gptkbp:research |
ongoing to understand variant better
|
| gptkbp:research_focus |
vaccine adaptation
|
| gptkbp:responds_to |
requires international cooperation
coordinated by WHO and health agencies requires updated health policies |
| gptkbp:risk_factor |
high
age and comorbidities |
| gptkbp:scientific_classification |
Variant of Concern
|
| gptkbp:side_effect |
increased hospitalizations
significant on resources |
| gptkbp:social_responsibility |
conducted to assess impact
|
| gptkbp:symptoms |
gptkb:standard
similar to other Omicron variants |
| gptkbp:track |
important for epidemiology
key for controlling spread |
| gptkbp:transmission |
airborne
|
| gptkbp:treatment |
similar to other COVID-19 treatments
|
| gptkbp:trigger_type |
recommended for enhanced protection
|
| gptkbp:variant |
gptkb:Omicron
developed by health organizations collected from multiple sources compared to Delta variant focus on transmissibility and severity high transmissibility and immune escape under continuous study |